Prescribing Details
Description
No Data
Uses
No Data
Indications
No Data
Dosage and administration
A small quantity of SKINALAR ® and SKINALAR ® –N is applied lightly up to two or three times a day, and massaged gently and thoroughly into the skin. These recommendations apply to both children and adults, including the elderly.
Use in pregnancy & lactation
SKINALAR ® Cream and Ointment are suitable for treating a wide variety of local inflammatory, pruritic and allergic disorders of the skin.
SKINALAR ® is particularly suitable for topical application in:
Eczema and dermatitis: Atopic eczema, seborrhoeic eczema, discoid eczema, otitis externa, contact dermatitis, neurodermatitis.
Prurigo, Psoriasis, lichen planus. Discoid lupus erythematosus.
SKINALAR ® -N is indicated for inflammatory dermatoses, where secondary bacterial infection is present or likely to occur.
Pregnancy: Topical administration of corticosteroids to pregnant animals can cause abnormalities of fetal development, including cleft palate intrauterine growth retardation. There may be a small risk of such effects on the human fetus.
Lactation: When topical steroid treatment is necessary, minimize amount and length of treatment.
Geriatric use
Precautions
SKINALAR ® – Appropriate anti-infective cover should be given if there is an associated infection.
SKINALAR ® -N – Appropriate anti-infective cover should be given in the presence of viral or fungal infection. Prolonged use should be avoided in conditions where absorption of neomycin is possible. Do not apply to the external auditory canal of patients with perforated eardrums.
SKINALAR ® and SKINALAR ® -N: Long-term continuous topical steroid therapy can produce atrophic skin changes. Do not apply to the face for prolonged periods. Prolonged use or treatment of extensive areas can produce adrenal suppression, especially in infants and children.
Side effects
With SKINALAR ® , side-effects are extremely rare, but as with all topical corticosteroids, patient may show hypersensitivity reaction.
Contraindications
SKINALAR ® – Primary infections of the skin and in rosacea, acne, perioral dermatitis, anogenital pruritis and napkin eruption.
SKINALAR ® -N – As for SKINALAR ® . Also known hypersensitivity to neomycin.
Drug interactions
No Data
Overdose
No Data
Preparation
No Data
Pharmaceutical precautions
Store at temperature below 30 0 C.
